Mesoblast (MESO) Retained Earnings (2015 - 2025)
Mesoblast's (MESO) quarterly Retained Earnings came in at $106.3 million in Q4 2025, up 8.74% year-on-year from $97.8 million in Q4 2024, and up 6.83% quarter-over-quarter from $99.5 million in Q2 2025.
Mesoblast (MESO) Retained Earnings (2015 - 2025) Analysis & Trends
Mesoblast has disclosed Retained Earnings across 11 years of filings, most recently posting $106.3 million for Q4 2025.
- Retained Earnings for Q4 2025 came in at $106.3 million, up 8.74% year-over-year; the trailing twelve-month figure through Dec 2025 was $106.3 million (up 8.74% YoY), and the FY2025 annual result was $99.5 million, up 110.95% from the prior year.
- Retained Earnings came in at $106.3 million for Q4 2025 at Mesoblast, up from $99.5 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $106.3 million in Q4 2025 to a low of -$908.8 million in Q2 2024.
- The 5-year median for Retained Earnings is $69.3 million (2022), against an average of -$4.8 million.
- Across the five-year window, Retained Earnings jumped 2492.8% in 2023 and sank 7107.18% in 2024, its largest moves.
- Mesoblast's Retained Earnings stood at $68.1 million in 2021, then increased by 6.6% to $72.6 million in 2022, then gained by 4.51% to $75.8 million in 2023, then gained by 28.88% to $97.8 million in 2024, then increased by 8.74% to $106.3 million in 2025.
- The last three Retained Earnings figures came in at $106.3 million (Q4 2025), $99.5 million (Q2 2025), and $97.8 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Mesoblast | 21.68 Bn | 21.55 Bn | - | 106.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 106.29 Mn |
| Jun 30, 2025 | 99.50 Mn |
| Dec 31, 2024 | 97.75 Mn |
| Jun 30, 2024 | -908.76 Mn |
| Dec 31, 2023 | 75.85 Mn |
| Jun 30, 2023 | 12.97 Mn |
| Mar 31, 2023 | 73.55 Mn |
| Dec 31, 2022 | 72.57 Mn |
| Sep 30, 2022 | 70.87 Mn |
| Jun 30, 2022 | -542,000.00 |
| Mar 31, 2022 | 69.28 Mn |
| Dec 31, 2021 | 68.08 Mn |
| Sep 30, 2021 | 66.47 Mn |
| Jun 30, 2021 | -39.79 Mn |
| Mar 31, 2021 | 64.25 Mn |
| Dec 31, 2020 | 52.19 Mn |
| Sep 30, 2020 | 48.80 Mn |
| Jun 30, 2020 | 85.33 Mn |
| Mar 31, 2020 | 43.51 Mn |
| Dec 31, 2019 | 42.05 Mn |